바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.69 No.6
Citation Share

Infection Rate of Chlamydia pneumoniae in Patients with Chronic Cough

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2010, v.69 no.6, pp.426-433

















& (2010). Infection Rate of Chlamydia pneumoniae in Patients with Chronic Cough. Tuberculosis & Respiratory Diseases, 69(6), 426-433.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Persistent cough has recently been found to be associated with Chlamydia pneumoniae infection. We aimed to investigate the infection rate of C. pneumonia in adult patients with chronic cough. Methods: We recruited 68 patients with persistent cough lasting in excess of 3 weeks, who visited Kangdong Sacred Heart Hospital from January 2005 to August 2005. On the first visit, chest and paranasal sinuses radiography, skin prick test of common allergens, and induced sputum samples for C. pneumoniae were performed in all of patients. Further evaluation for diagnosis included a methacholine provocation test and eosinophil counts in induced sputum. Results: The most common cause of chronic cough was upper airway cough syndrome (UACS) (26.5%), followed by eosinophilic bronchitis (20.6%) and cough variant asthma (16.2%). Idiopathic chronic cough was the cause in 33.8% of patients. The mean duration of cough was 11.7 months. C. pneumoniae was isolated by polymerase chain reaction (PCR) from one patient who had upper respiratory air way syndrome. Conclusion: Chlamydia pneumoniae appears to have a minor role as a cause of chronic cough in patients.

keywords
Cough, Polymerase Chain Reaction, Chlamydia Infections, Cough, Polymerase Chain Reaction, Chlamydia Infections

Reference

1.

1. Irwin RS, Rosen MJ, Braman SS. Cough. A comprehensive review. Arch Intern Med 1977;137:1186-91.

2.

2. Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981;123:413-7.

3.

3. Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990;141:640-7.

4.

4. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999;160:406-10.

5.

5. Grayston JT, Wang S. New knowledge of chlamydiae and the diseases they cause. J Infect Dis 1975;132:87-105.

6.

6. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.

7.

7. Hyman CL, Augenbraun MH, Roblin PM, Schachter J,Hammerschlag MR. Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR. J Clin Microbiol 1991;29:2082-3.

8.

8. Hyman CL, Roblin PM, Gaydos CA, Quinn TC,Schachter J, Hammerschlag MR. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995;20:1174-8.

9.

9. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. Chlamydia pneumoniae infection in adult patients with persistent cough. J Med Microbiol 2003;52:265-9.

10.

10. Kim WJ, Lee HY, Lee ME, Lee SJ. Serology of Chlamydia pneumoniae in patients with chronic cough.Respirology 2006;11:805-8.

11.

11. Smieja M, Mahony JB, Goldsmith CH, Chong S, Petrich A, Chernesky M. Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens. J Clin Microbiol 2001;39:1796-801.

12.

12. Lee HS, Chun BY, Jin SH, Lee WK. Infection rate of Chlamydia pneumoniae by serological antibody test between patients with respiratory symptoms and control group. Korean J Clin Microbiol 2004;7:31-7.

13.

13. Gnarpe J, Eriksson K. Sample preparation for Chlamydia pneumoniae PCR. APMIS 1995;103:307-8.

14.

14. Tong CY, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993;46:313-7.

15.

15. Lee WK. Chlamydia pneumoniae and Atherosclerosis.Korean J Clin Microbiol 2001;4:78-81.

16.

16. Lee EM, Oh DJ, Hwang GS, Ahn JC, Song WH, Lim DS, et al. Chronic chlamydia pneumoniae infection as a risk factor for acute myocardial infarction in Korea.Korean Circ J 2000;30:407-15.

17.

17. File TM Jr, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae,and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am 1998;12:569-92.

18.

18. Hahn DL, Anttila T, Saikku P. Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect 1996;117:513-7.

19.

19. Black PN, Scicchitano R, Jenkins CR, Blasi F, Allegra L, Wlodarczyk J, et al. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J 2000;15:254-9.

20.

20. Miyashita N, Kubota Y, Nakajima M, Niki Y, Kawane H, Matsushima T. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 1998;80:405-9.

21.

21. Black PN, Blasi F, Jenkins CR, Scicchitano R, Mills GD,Rubinfeld AR, et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001;164:536-41.

22.

22. Ferrari M, Poli A, Olivieri M, Verlato G, Tardivo S,Nicolis M, et al. Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults. Infection 2002;30:203-7.

23.

23. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001;33:492-503.

24.

24. Hermann C, Gueinzius K, Oehme A, Von Aulock S,Straube E, Hartung T. Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol 2004;42:2476-9.

25.

25. Park J, Kim JK, Rheem I, Kim J. Evaluation of Seeplex Pneumobacter multiplex PCR kit for the detection of respiratory bacterial pathogens in pediatric patients.Korean J Lab Med 2009;29:307-13.

26.

26. Park SE, Choi SE, Jung HS, Kwak YH, Lee HJ.Detection of Chlamydia pneumoniae by use of the nested polymerase chain reaction in children with lower respiratory tract infection. Korean J Infect Dis 1999;31:197-202.

27.

27. Birkebaek NH, Jensen JS, Seefeldt T, Degn J, Huniche B, Andersen PL, et al. Chlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors. Eur Respir J 2000;16:108-11.

28.

28. Boman J, Gaydos CA, Quinn TC. Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol 1999;37:3791-9.

29.

29. Block S, Hedrick J, Hammerschlag MR, Cassell GH,Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia:comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995;14:471-7.

30.

30. Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M,Dumornay W, Mandel L, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14:178-82.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy